2024 France Hospital Infectious Disease Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for 100 Tests, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

August 2024 | | ID: F754415F0919EN
Venture Planning Group

Abstracts

This new report from LeadingMarketResearch.com contains 897 pages and 7 tables.The report is available by section, and can be customized to specific information needs and budget.The report presents a comprehensive analysis of the French hospital infectious disease testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.;Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms.;Volume and sales forecasts for 80 infectious disease tests performed in French hospital laboratories.;Instrumentation technologies and feature comparison of leading analyzers.;Sales and market shares of & leading suppliers by test.;  Emerging diagnostic technologies and their potential market applications.;Product development opportunities. Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.;Business opportunities and strategic recommendations for suppliers.Contains 897 pages and 77 tables

Contents

Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests

1. AIDS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

2. ADENOVIRUS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)

3. AEROMONAS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

4. ANTHRAX/BACILLUS ANTHRACIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

5. ARBOVIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

6. BABESIOSIS

a. Background

7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA) AND OTHER

Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

8. BLASTOCYSTIS HOMINIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs


9. BRUCELLA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

10. CAMPYLOBACTER

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

11. CANDIDA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

12. CHAGAS DISEASE

a. Background

13. CHANCROID

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

14. CHLAMYDIA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

15. CLOSTRIDIUM DIFFICILE

a. Background
b. Diagnostic Tests
c. Drugs and Vaccines

16. CORONAVIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

17. COXSACKIEVIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

18. CREUTZFELDT-JAKOB’S DISEASE

a. Background
b. Diagnostic Tests
c. Vaccines